CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more


Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Researchers compare treatments for uveitis

A new study has found that methotrexate performs at a similar level to the more expensive mycophenolate mofetil in treating non-infectious uveitis

Pills in hand

US scientists have compared the effectiveness of two treatments for uveitis, methotrexate and mycophenolate mofetil.

Writing in the Journal of the American Medical Association, researchers highlight that both treatments performed similarly in treating non-infectious uveitis.
However, the trial found that in cases of posterior uveitis and panuveitis, the less expensive methotrexate was more effective in controlling infection.

The study involved 216 uveitis patients from India, the US, Australia, Saudi Arabia and Mexico who were assigned either methotrexate or mycophenolate mofetil.

At six months, 67% of participants in the group assigned methotrexate and 57% of patients given mycophenolate mofetil had controlled their inflammation.

In patients with the most severe forms of uveitis, posterior uveitis and panuveitis, 74% of patients in the methotrexate group achieved control at six months compared to 55% in the mycophenolate mofetil group.

Total rates of adverse effects were similar between the two drugs.

Image credit: Pixabay/jarmoluk